Kolerasi Indeks Obesitasa dengan Kadar Neutrophil Gelatinase Associated Lipocalin (NGAL) pada Subyek Dewasa Non-Diabetes Melitus
Keywords:
Neutrophil Gelatinase Associated Lipocalin (NGAL), Indeks Massa Tubuh, Lingkar Pinggang, Persen Lemak Tubuh, Lemak VisceralAbstract
Korelasi Indeks Obesitas Dengan Kadar Neuthrophil Gelatinase Associated Lipocalin (NGAL) Pada Subjek Dewasa Non-Diabetes Melitus. (Dibimbing oleh Liong Boy Kurniawan dan Yuyun Widaningsih). Penelitian ini bertujuan untuk mengetahui kolerasi indeks obesitas dengan kadar Neuthrophil Gelatinase Associated Lipocalin (NGAL) pada subjek dewasa Non-Diabetes Melitus. Sebanyak 70 sampel yang memenuhi kriteria inklusi dan eksklusi, terdiri dari 17 laki-laki obesitas, 18 laki-laki non-obesitas, 17 perempuan obesitas, dan 18 perempuan non obesitas. Metode penelitian ini adalah cross sectional study. Hasil penelitian ini menunjukkan bahwa tidak terdapat korelasi antara Neuthrophil Gelatinase Associated Lipocalin dengan IMT (p = 0,241, r = 0,142), LP (p = 0,204, r = -0,154), % Lemak Tubuh (p = 0,984, r = -0,02), LemakVisceral (p = 0,955 r = 0,007) pada subjek dewasa non diabetes melitus. Kesimpulan penelitian yaitu tidak ada kolerasi indeks obesitas dengan kadar Neuthrophil Gelatinase Associated Lipocalin pada subjek dewasa non diabetes melitus (DM)
References
Misnadierly, 2007. Obesitas Sebagai Faktor Resiko Berbagai Penyakit. Jakarta : Pustaka Obor Papuler
Soegih, R. Rachmad, and Kunkun K Wiramihardja. 2009. "Obesitas: Permasalahan Dan Terapi Praktis." 1st ed. Jakarta: Sagung Seto.
Després, Jean-Pierre. 2006. “Abdominal Obesity: The Most Prevalent Cause of the Metabolic Syndrome and Related Cardiometabolic Risk.” European Heart Journal Supplements 8(suppl_B): B4–12.
KEMENKES, Kementerian Kesehatan Republik Indonesia. 2019. Batas Ambang Indeks Masa Tubuh." Direktorat Pencegahan Dan Pengendalian Penyakit Tidak Menular Kementerian Kesehatan Republik Indonesia.
Bertin, B., Desreumaux, P. & Dubuquoy, L. Obesity , visceral fat and Crohn ’ s disease. (2010). doi:10,1097/MCO.0b013e32833cf0f4
Listiyana, Aulia Dewi, Mardiana Mardiana, and Galuh Nita Prameswari. 2013. “Obesitas Sentral Dan Kadar Kolesterol Darah Total.” Jurnal Kesehatan Masyarakat 9(1): 37–43.
Jansen, 2016. Ketahui Kadar Lemak Tubuh anda, avalaible from http://www.ask-jansen.com/kadar-lemak-tubuh/, accesed tanggal 5 Desember 2016.
Dewi Up, Dieny Ff. Hubungan antara densitas energi dan kualitas diet dengan indeks massa tubuh (IMT) pada remaja Journal of Nutrition College 2013, 2 (4);445-57.
Droletet al.(2008).Hypertrophy and Hyperplasia of Abdominal Adipose Tissues in Women.International Journal of Obesity : Nature Publishing Group.
Mustakin. 2016. “Analisis Kadar Adiponektin Dan Lipocalin-2 Serum Pada Subyek Obesitas Sentral Dengan Prediabetes.” Tesis. Makassar: Pendidikan Dokter Spesialis Universitas Hasanuddin.
Daniels L.B, Barrett-Connor E, Clopton P, Laughlin G.AJoachim H. Maisel A.S, 2012, “Plasma Neutrophil Gelatinase–Associated Lipocalin Is Independently Associated With Cardiovascular Disease and Mortality in Community-Dwelling Older Adults”, in :Journal of the American College of Cardiology Vol. 59, No. 12, p: 1101-1109.
El-Mesallamy HO, Hamdy NM, Sallam AA. Efek obesitas dan glikemik kontrol pada serum lipocalin dan sumbu faktor pertumbuhan seperti insulin dalam tipe 2 subjek diabetes. Akta Diabetes. 2013;50(5):67985. doi:10,1007/s00592-012-0373-6 .
Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, Tso AW, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem. 2007;53(1):34–41. doi: 10,1373/clinchem.2006.075614.
Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, dkk. Identifikasilipocalin terkait gelatinase neutrofil sebagai bioteknologi urin awal yang baru penanda untuk cedera ginjal iskemik. J Am Soc Nephrol. 2003;14(10):2534–43
Published
How to Cite
Issue
Section
Authors who publish with Poltekita : Jurnal Ilmu Kesehatan agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
This work is licensed under a Creative Commons Attribution-ShareAlike 2.0 Generic License.
Poltekita : Jurnal Ilmu Kesehatan is licensed under a Creative Commons Attribution-Share Alike 4.0 International License
You are free to:
- Share, copy and redistribute the material in any medium or format
- Adapt, remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
